Skip to content

N Latex Cystatin

by Dade Behring, Inc. 510(k)

Active United States

510(k) K041878

Overview

The N Latex Cystatin is an in vitro diagnostic reagent kit classified as a Test, Cystatin C (Product Code: NDY). It is designed for the quantitative measurement of cystatin C in human serum and heparinized plasma using particle-enhanced immunonephelometry on BN™ Systems. The device employs polystyrene particles coated with anti-human cystatin C antibodies to detect and quantify the analyte through aggregation in patient samples.

This device is supplied as a reagent kit for laboratory use and is intended for single-use. It is regulated under FDA 510(k) clearance (K041878) and falls under Class II – Special Controls as defined by § 862.1225. The device requires proper storage and handling in a clinical chemistry setting, adhering to standard laboratory protocols for in vitro diagnostics. No MRI safety or sterility specifications are indicated in the available data.

AI-generated from registry data, 19 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK041878 Date16 Aug 2004ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
NDY
Device Class
Class II
Regulation
21 CFR Part 862.1225
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Dade Behring, Inc.

See all devices from Dade Behring, Inc. →

Questions

  • What clinical chemistry applications is the N Latex Cystatin intended for in a laboratory setting?

    The N Latex Cystatin is designed specifically for the quantitative measurement of cystatin C in human serum and heparinized plasma. It uses particle-enhanced immunonephelometry on BN™ Systems to detect and quantify this biomarker, which is commonly used as an indicator of kidney function and glomerular filtration rate (GFR) assessment.

  • How is the N Latex Cystatin supplied, and is it meant for single-use or repeated use?

    The N Latex Cystatin is supplied as a reagent kit for laboratory use. According to the data, it is intended for single-use only, meaning each kit should not be reused after opening or exposure to patient samples.

  • What storage and handling requirements should be followed for this diagnostic reagent?

    While specific storage conditions (e.g., temperature) aren’t detailed in the provided data, the N Latex Cystatin is classified as a laboratory reagent kit for in vitro diagnostics. It must be stored and handled in compliance with standard clinical chemistry protocols to ensure accuracy and reliability of cystatin C measurements.

  • Does this device require any special regulatory approvals, and how was its equivalence determined?

    The N Latex Cystatin holds an FDA 510(k) clearance (K041878), classified under Class II – Special Controls for § 862.1225. Its equivalence was determined through a Traditional 510(k) review by the FDA’s Clinical Chemistry (CH) Advisory Committee, with a decision dated August 16, 2004, confirming it as substantially equivalent to a predicate device.